APA

Schafer E. S., Rau R. E., Berg S. L., Liu X., Minard C. G., Bishop A. J. R., Romero J. C., Hicks M. J., Nelson M. D., Voss S., Reid J. M., Fox E., Weigel B. J. & Blaney S. M. (20200422). Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). : Pediatric blood & cancer.

Chicago

Schafer Eric S, Rau Rachel E, Berg Stacey L, Liu Xiaowei, Minard Charles G, Bishop Alexander J R, Romero J Carolina, Hicks M John, Nelson Marvin D, Voss Stephan, Reid Joel M, Fox Elizabeth, Weigel Brenda J and Blaney Susan M. 20200422. Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). : Pediatric blood & cancer.

Harvard

Schafer E. S., Rau R. E., Berg S. L., Liu X., Minard C. G., Bishop A. J. R., Romero J. C., Hicks M. J., Nelson M. D., Voss S., Reid J. M., Fox E., Weigel B. J. and Blaney S. M. (20200422). Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). : Pediatric blood & cancer.

MLA

Schafer Eric S, Rau Rachel E, Berg Stacey L, Liu Xiaowei, Minard Charles G, Bishop Alexander J R, Romero J Carolina, Hicks M John, Nelson Marvin D, Voss Stephan, Reid Joel M, Fox Elizabeth, Weigel Brenda J and Blaney Susan M. Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). : Pediatric blood & cancer. 20200422.